Abstract Alzheimer's disease (AD), the most common form of dementia worldwide, is a mixed
proteinopathy (β-amyloid, tau and other proteins). Classically defined as a …

Alzheimer disease (AD), the most common form of dementia globally, classically defined a
clinicopathological entity, is a heterogenous disorder with various pathobiological subtypes …

Alzheimer disease (AD), the most common form of dementia, is a heterogenous disorder
with various pathobiological subtypes. In addition to the 4 major subtypes based on the …

With increasing knowledge of clinical in vivo biomarkers and the pathological intricacies of
Alzheimer's disease (AD), nosology is evolving. Harmonized consensus criteria that …

The distribution of Alzheimer's disease (AD) tau pathology varies systematically and causes
a diverse array of syndromes. This forum article provides a brief overview of key …

Objective To test the hypothesis that distinct subtypes of Alzheimer disease (AD) exist and
underlie the heterogeneity within AD, we conducted a systematic review and meta-analysis …

Abstract See Coulthard and Knight (doi: 10.1093/aww335) for a scientific commentary on
this article. Individuals with mild cognitive impairment and Alzheimer's disease clinical …

Alzheimer disease (AD) is a chronic disease characterized by a progressive decline in
memory and cognition. AD progression is closely correlated with neuropathologic changes …

Alzheimer disease (AD) is biologically defined by the presence of β-amyloid-containing
plaques and tau-containing neurofibrillary tangles. AD is a genetic and sporadic …

The definitive diagnosis of Alzheimer's disease (AD) rests with post-mortem neuropathology
despite the advent of more sensitive scanning and the search for reliable biomarkers. Even …